Invention Grant
US09228998B2 Drug monitoring methods using the promyelocytic leukemia protein as a redox sensor
有权
药物监测方法使用早幼粒细胞白血病蛋白作为氧化还原传感器
- Patent Title: Drug monitoring methods using the promyelocytic leukemia protein as a redox sensor
- Patent Title (中): 药物监测方法使用早幼粒细胞白血病蛋白作为氧化还原传感器
-
Application No.: US14200436Application Date: 2014-03-07
-
Publication No.: US09228998B2Publication Date: 2016-01-05
- Inventor: Hugues De The , Valerie Lallemand-Breitenbach
- Applicant: Institut National de la Sante et de la Recherche Medicale (INSERM)
- Applicant Address: FR Paris FR Paris
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITE PARIS DIDEROT—PARIS 7
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITE PARIS DIDEROT—PARIS 7
- Current Assignee Address: FR Paris FR Paris
- Agency: Whitham, Curtis, Christofferson & Cook, P.C.
- Priority: EP10305034 20100113
- Main IPC: G01N33/50
- IPC: G01N33/50 ; G01N33/566 ; G01N33/68 ; C07K14/47 ; C07K14/555
Abstract:
The present invention relates to a method for determining the redox status of a cell or tissue comprising a step consisting of determining the level of PML nuclear bodies in said cell or tissue.
Public/Granted literature
- US20140205568A1 Promyelocytic Leukemia Protein as a Redox Sensor Public/Granted day:2014-07-24
Information query
IPC分类:
